Betting Against Semiconductors: A Contrarian Bet Gone Sour
A bold contrarian wager on semiconductors has underperformed as AI demand sustains a rally. Leveraged, daily-reset fu...
Which Stablecoins Are Regulated
We review which stablecoins fall under regulatory scrutiny, the regimes that apply, and practical implications for users and providers alike.
19,598 articles
JEPQ’s 0.35% Hides a 9-Point Gap in Income Returns
A closer look at JEPQ reveals a persistent gap between monthly income and total returns. The premium income ETF pays ...
Carnival Earnings Anxiety: Good, Bad, Ugly for Investors
Cruise investors wrestle with Carnival earnings anxiety: good, the push-pull between sunny passenger demand and risin...
Tesla Cofounder Straubel’s First Pitch Turned Triumph
JB Straubel’s initial pitch to Elon Musk missed the mark on aviation, but his pivot to electric cars launched Tesla t...
Inside Mind Active Trader: Leveraged ETFs in Major Moves
Retail traders drove a large share of leveraged ETF activity in late 2025 as markets swung. This piece examines the p...
Why I Can’t Stop Buying This 136-Year-Old Dividend King
In a market rattled by softer data, Coca-Cola’s traditional strengths keep drawing new and seasoned investors alike. ...
The United States Undermining Hormuz Crisis Deepens
Oil markets bounce as Strait of Hormuz risks flare and Beijing delays a high-stakes summit. The United States undermi...
Micron Just Dropped 13%: Analyst Says Rally Stays Intact
Micron Technology shares tumbled about 13% ahead of its fiscal Q3 print, but one analyst argues the slide is a sentim...
Arthur Hayes Bought ETHFI; Upbit Listing Triggers Big Buzz
Former BitMEX chief Arthur Hayes reportedly acquired a tranche of ETHFI ahead of Upbit's listing, sparking a price sp...
Hugh Jackman Says Brutal Budget Lessons From Hard Fights
A Hollywood heavyweight once described a fight as the hardest thing he’s ever done. The lesson translates perfectly t...
Wall Street Expected Soar: Why SYM Bulls May Fall Short
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status